Belite Bio Inc ADR (BLTE) — Net Asset Quality Index
Belite Bio Inc ADR (BLTE) has a Net Asset Quality Index of 98.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $811.27 Million minus total liabilities of $15.48 Million yields net assets of $795.79 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Belite Bio Inc ADR total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Belite Bio Inc ADR Net Asset Quality Index Over Time (2020–2025)
This chart shows how Belite Bio Inc ADR's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the index stands at 98.1%, representing net assets of $795.79 Million against total assets of $811.27 Million USD. For live market cap and overall valuation, see Belite Bio Inc ADR (BLTE) total market value.
Annual Net Asset Quality Index for Belite Bio Inc ADR (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Belite Bio Inc ADR from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Belite Bio Inc ADR PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.7% | $770.49 Million | $780.56 Million | $10.07 Million | ▲ +2.9 pp |
| 2024 | 95.9% | $145.82 Million | $152.13 Million | $6.31 Million | ▲ +0.3 pp |
| 2023 | 95.6% | $90.43 Million | $94.64 Million | $4.21 Million | ▲ +1.8 pp |
| 2022 | 93.7% | $41.50 Million | $44.27 Million | $2.77 Million | ▲ +176.0 pp |
| 2021 | -82.3% | $-15.09 Million | $18.35 Million | $33.44 Million | ▼ -54.9 pp |
| 2020 | -27.3% | $-7.04 Million | $25.74 Million | $32.78 Million | — |